Cited by 251Smoking Behavior and CessationCannabis and Cannabinoid ResearchNicotinic Acetylcholine Receptors Study

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

Cohen, Caroline, Perrault, Ghislaine, Griebel, Guy, Soubrié, Philippe·2005·Neuropsychopharmacology

Open this paper in CoChat — free account

Abstract

Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300541

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Limbic Activation During Cue-Induced Cocaine Craving
Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O’Brien, C. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.11 · Cited by 1,513
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355
Subsecond dopamine release promotes cocaine seeking
Phillips, P. E. M., Stuber, G. D., Heien, M. L. A. V., Wightman, R. M., & Carelli, R. M. (2003) · Nature · doi:10.1038/nature01476 · Cited by 1,113
Incubation of cocaine craving after withdrawal
Grimm, J. W., Hope, B. T., Wise, R. A., & Shaham, Y. (2001) · Nature · doi:10.1038/35084134 · Cited by 1,031
The neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 593
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M. A., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565

Show all 51 references

Sorted by citations

The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Targeting the endocannabinoid system: to enhance or reduce?
Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 822
Involvement of the endocannabinoid system in drug addiction
Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 601
Nicotine use in schizophrenia: The self medication hypotheses
Kumari, V., & Postma, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.02.006 · Cited by 470
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 294
Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement
Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0178-1 · Cited by 271
Leptin Resistance and Obesity
Enriori, P. J., Evans, A. E., Sinnayah, P., & Cowley, M. A. (2006) · Obesity · doi:10.1038/oby.2006.319 · Cited by 281
Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity
Kenny, P. J., & Markou, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300905 · Cited by 261
The endocannabinoid system in brain reward processes
Solinas, M., Goldberg, S. R., & Piomelli, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.130 · Cited by 251
Parallel goal-directed and habitual control of human drug-seeking: Implications for dependence vulnerability.
Hogarth, L., & Chase, H. W. (2011) · Journal of Experimental Psychology: Animal Behavior Processes · doi:10.1037/a0022913 · Cited by 225
Tobacco addiction
Hatsukami, D. K., Stead, L. F., & Gupta, P. C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60871-5 · Cited by 227
The Role of Nicotine in Smoking: A Dual-Reinforcement Model
Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., Chaudhri, N., & Sved, A. F. (2008) · Nebraska Symposium on Motivation · doi:10.1007/978-0-387-78748-0_6 · Cited by 226
Cannabinoids in health and disease
Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 227
Cannabinoid CB1 receptors control conditioned drug seeking
Vries, T. J. D., & Schoffelmeer, A. N. M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.002 · Cited by 219
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Morgan, C. J. A., Das, R., Joye, A., Curran, H. V., & Kamboj, S. K. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.011 · Cited by 194
Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties
Foll, B. L., & Goldberg, S. R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_12 · Cited by 200
Tobacco and cannabis co-occurrence: Does route of administration matter?
Arpana Agrawal, A., & Lynskey, M. T. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.007 · Cited by 182
Smoking tobacco along with marijuana increases symptoms of cannabis dependence
Ream, G. L., Benoit, E., Johnson, B. D., & Dunlap, E. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.011 · Cited by 181
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers
Palmatier, M. I., Evans-Martin, F. F., Hoffman, A., Caggiula, A. R., Chaudhri, N., Donny, E. C., Liu, X., Booth, S., Gharib, M. A., Craven, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0183-4 · Cited by 169
Translational research in medication development for nicotine dependence
Lerman, C. E., LeSage, M. G., Perkins, K. A., O’Malley, S. S., Siegel, S. J., Benowitz, N. L., & Corrigall, W. A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2361 · Cited by 150
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system
Berrendero, F., Robledo, P., Trigo, J. M., Martín-García, E., & Maldonado, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.02.006 · Cited by 140
Treatment of nicotine addiction: present therapeutic options and pipeline developments
Polosa, R., & Benowitz, N. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.008 · Cited by 135
Nicotine as a typical drug of abuse in experimental animals and humans
Foll, B. L., & Goldberg, S. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0155-8 · Cited by 133
Extended Access to Nicotine Self-Administration Leads to Dependence: Circadian Measures, Withdrawal Measures, and Extinction Behavior in Rats
O’Dell, L. E., Chen, S. A., Smith, R. T., Specio, S. E., Balster, R. L., Paterson, N. E., Markou, A., Zorrilla, E. P., & Koob, G. F. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105270 · Cited by 128
Role of cues and contexts on drug‐seeking behaviour
Perry, C. J., Zbukvic, I., Kim, J. H., & Lawrence, A. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12735 · Cited by 141
Update on Pharmacologic Options for Smoking Cessation Treatment
Nides, M. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.016 · Cited by 130
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 132
Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine
Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M., Craven, L., Palmatier, M. I., Liu, X., & Sved, A. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0522-0 · Cited by 123
The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
O’Connor, E. C., Parker, D., Rollema, H., & Mead, A. N. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1739-5 · Cited by 118
CB receptor antagonists for the treatment of nicotine addiction
Cohen, C., Kodas, E., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.024 · Cited by 123
Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats
Forget, B., Hamon, M., & Thiébot, M.-H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0015-6 · Cited by 116
The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence
Merritt, L. L., Martin, B. R., Walters, C., Lichtman, A. H., & Damaj, M. I. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138321 · Cited by 113
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Blocking cannabinoid CB1receptors for the treatment of nicotine dependence: insights from pre‐clinical and clinical studies
Foll, B. L., Forget, B., Aubin, H., & Goldberg, S. R. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00113.x · Cited by 108
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice
Balerio, G. N., Aso, E., & Maldonado, R. J. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0251-9 · Cited by 104
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99
Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans
Foll, B. L., & Goldberg, S. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.005 · Cited by 102
Endocannabinoid system involvement in brain reward processes related to drug abuse
Solinas, M., Yaşar, S., & Goldberg, S. R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.005 · Cited by 102
Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule
Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M. A., Craven, L., Palmatier, M. I., Liu, X., & Sved, A. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0454-8 · Cited by 97
Neuropharmacology and potential efficacy of new treatments for tobacco dependence
Fagerström, K. O., & Balfour, D. J. K. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.2.107 · Cited by 95
α-Conotoxin MII-Sensitive Nicotinic Acetylcholine Receptors in the Nucleus Accumbens Shell Regulate Progressive Ratio Responding Maintained by Nicotine
Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95
“Cues greatly enhance nicotine self-administration in rodents (Caggiula et al, 2001; Caggiula et al , 2002) and can sustain self-administration and smoking behaviors in the absence of nicotine (Cohen et al , 2005; Donny et al , 2007).”
The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats
Shoaib, M. C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.011 · Cited by 93
The role of CB1 receptors in psychostimulant addiction
Wiskerke, J., Pattij, T., Schoffelmeer, A. N. M., & Vries, T. J. D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00109.x · Cited by 91
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Rimonabant: The first therapeutically relevant cannabinoid antagonist
Carai, M. A. M., Colombo, G., & Gessa, G. L. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.017 · Cited by 90
Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour
Keeney, B. K., Raichlen, D. A., Meek, T. H., Wijeratne, R. S., Middleton, K. M., Gerdeman, G. L., & Garland, T. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32831c3b6b · Cited by 86
Behavioral Mechanisms Underlying Nicotine Reinforcement
Rupprecht, L. E., Smith, T. T., Schassburger, R. L., Buffalari, D. M., Sved, A. F., & Donny, E. C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_2 · Cited by 91
The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice
Ignatowska-Jankowska, B. M., Muldoon, P. P., Lichtman, A. H., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3117-6 · Cited by 88
Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine.
Filip, M., Gołda, A., Zaniewska, M., McCreary, A. C., Nowak, E., Kolasiewicz, W., & Przegaliński, E. (2006) · PubMed · Cited by 83
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use
Xie, S., Furjanic, M. A., Ferrara, J., McAndrew, N. R., Ardino, E. L., Ngondara, A., Bernstein, Y., Thomas, K. J., Kim, E., Walker, J. M., et al. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00817.x · Cited by 82
Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A)
Diergaarde, L., de Vries, W., Raasø, H. S., Schoffelmeer, A. N. M., & Vries, T. J. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.003 · Cited by 80
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Zlebnik, N. E., & Cheer, J. F. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014038 · Cited by 82
Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose
Liu, X., Caggiula, A. R., Palmatier, M. I., Donny, E. C., & Sved, A. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0967-9 · Cited by 78
The CB1Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Gueye, A. B., Pryslawsky, Y., Trigo, J. M., Poulia, N., Delis, F., Antoniou, K., Loureiro, M., Laviolette, S. R., Vemuri, K., Makriyannis, A., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw068 · Cited by 74
Varenicline in the treatment of tobacco dependence
Fagerström, K. O. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s927 · Cited by 78
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
Bifulco, M., Grimaldi, C., Gazzerro, P., Pisanti, S., & Santoro, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033118 · Cited by 74
Cannabinoid modulation of drug reward and the implications of marijuana legalization
Covey, D. P., Wenzel, J. M., & Cheer, J. F. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.034 · Cited by 75
Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats
Liu, X., Palmatier, M. I., Caggiula, A. R., Donny, E. C., & Sved, A. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0863-3 · Cited by 78
β2-Subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice
Brunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0099-z · Cited by 71
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain
Rigotti, N. A., Gonzales, D. H., Dale, L. C., Lawrence, D. L., & Chang, Y. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02454.x · Cited by 71
Vaccination against nicotine: an emerging therapy for tobacco dependence
Maurer, P., & Bachmann, M. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1775 · Cited by 70
Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine
Palmatier, M. I., Liu, X., Matteson, G. L., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0897-6 · Cited by 70
Non-Nicotinic Therapies for Smoking Cessation
Siu, E. C. K., & Tyndale, R. F. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105354 · Cited by 69
Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats
Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Poland, R. E., & Pechnick, R. N. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0134-0 · Cited by 70
Mecamylamine Attenuates Cue-Induced Reinstatement of Nicotine-Seeking Behavior in Rats
Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Sved, A. F., Pechnick, R. N., & Poland, R. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301129 · Cited by 69
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
Johnson, K. A., & Lovinger, D. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00264 · Cited by 67
High Reinforcing Efficacy of Nicotine in Non-Human Primates
Foll, B. L., Wertheim, C. E., & Goldberg, S. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000230 · Cited by 66
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats
Li, J., Qiu, Y., Zhang, Y., & Li, J. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.004 · Cited by 65
Effects of nicotine on homeostatic and hedonic components of food intake
Stojakovic, A., Espinosa, E. V. P., Farhad, O. T., & Lutfy, K. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0166 · Cited by 65
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Kruk-Słomka, M., Michalak, A., & Biała, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.051 · Cited by 64
Ecological momentary assessment of working memory under conditions of simultaneous marijuana and tobacco use
Schuster, R. M., Mermelstein, R. J., & Hedeker, D. (2016) · Addiction · doi:10.1111/add.13342 · Cited by 69
Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats
Liu, X., Jernigen, C., Gharib, M. A., Booth, S., Caggiula, A. R., & Sved, A. F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328337be95 · Cited by 61
Nicotine and Hippocampus-Dependent Learning: Implications for Addiction
Gould, T. J. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:2:93 · Cited by 61
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
The reinforcement-enhancing effects of nicotine: Implications for the relationship between smoking, eating and weight
Donny, E. C., Caggiula, A. R., Weaver, M. T., Levin, M. E., & Sved, A. F. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.043 · Cited by 61
Serotonin receptors as potential targets for modulation of nicotine use and dependence
Fletcher, P. J., LE, A., & Higgins, G. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00918-7 · Cited by 61
Role of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
Scherma, M., Muntoni, A. L., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 59
Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant
Gerdeman, G. L., Schechter, J. B., & French, E. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301648 · Cited by 56
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women
Janes, A. C., Smoller, J. W., David, S. P., Frederick, B. B., Haddad, S. A., Basu, A., D, M. F. M., Evins, A. E., & Kaufman, M. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.009 · Cited by 57
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
The inverse agonist of CB1 receptor SR 141716 blocks compulsive eating of palatable food
Dore, R., Valenza, M., Wang, X., Rice, K. C., Sabino, V., & Cottone, P. (2013) · Addiction Biology · doi:10.1111/adb.12056 · Cited by 51
The effect of nicotine on sign-tracking and goal-tracking in a Pavlovian conditioned approach paradigm in rats
Palmatier, M. I., Marks, K. R., Jones, S. A., Freeman, K. S., Wissman, K. M., & Sheppard, A. B. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2892-9 · Cited by 50
SLV330, a cannabinoid CB1 receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats
de Bruin, N. M. W. J., Lange, J. H. M., Kruse, C. G., Herremans, A. H. J., Schoffelmeer, A. N. M., Drimmelen, M. V., & Vries, T. J. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.013 · Cited by 50
Associative Learning, the Hippocampus, and Nicotine Addiction
Gould, T. J., & Davis, J. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010009 · Cited by 49
Endocannabinoid regulation of relapse mechanisms
Fattore, L., Fadda, P., & Fratta, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.004 · Cited by 49
Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats
Zaniewska, M., McCreary, A. C., Przegaliński, E., & Filip, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.034 · Cited by 46
Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats
Liu, X., Palmatier, M. I., Caggiula, A. R., Sved, A. F., Donny, E. C., Gharib, M. A., & Booth, S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1335-0 · Cited by 46
Serotonergic mechanisms in addiction-related memories
Dhonnchadha, B. Á. N., & Cunningham, K. A. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.026 · Cited by 44
Impact of Tobacco Regulation on Animal Research: New Perspectives and Opportunities
Donny, E. C., Taylor, T. G., LeSage, M. G., Levin, M., Buffalari, D. M., Joel, D., & Sved, A. F. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts162 · Cited by 46
Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders
Beardsley, P. M., & Thomas, B. F. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00003 · Cited by 44
Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling
Kodas, E., Cohen, C., Louis, C., & Griebel, G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0813-0 · Cited by 45
Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats
Biała, G., & Budzyńska, B. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.005 · Cited by 45
Nicotinic Facilitation of Δ9-Tetrahydrocannabinol Discrimination Involves Endogenous Anandamide
Solinas, M., Scherma, M., Tanda, G., Wertheim, C. E., Fratta, W., & Goldberg, S. R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116830 · Cited by 43
Rimonabant: endocannabinoid inhibition for the metabolic syndrome
Wierzbicki, A. S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01210.x · Cited by 43
Pooled analysis of three randomized, double‐blind, placebo controlled trials with rimonabant for smoking cessation
Robinson, J. D., Cinciripini, P. M., Karam‐Hage, M., Aubin, H., Dale, L. C., NIAURA, R. S., Anthenelli, R. M., & the STRATUS Group (2017) · Addiction Biology · doi:10.1111/adb.12508 · Cited by 43
Facilitation of intravenous nicotine self-administration in rats by a motivationally neutral sensory stimulus
Sorge, R. E., Pierre, V. J., & Clarke, P. B. S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1647-8 · Cited by 43
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Biała, G., Kruk, M., & Budzyńska, B. (2009) · PubMed · Cited by 41

Authors: Cohen, C., Perrault, G., Griebel, G., & Soubrié, P.
Affiliations: Sanofi (France) (FR)
Corresponding author: Cohen, Caroline
ORCID: Griebel, Guy
Venue: Neuropsychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2004-08-04
Volume: 30
Issue: 1
Pages: 145-155
ISSN: 0893-133X (ISSN-L)
1740-634X
DOI: 10.1038/sj.npp.1300541
OpenAlex: W2070212982
Cited by: 251
References: 51
Citations by year: 2025: 1 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 11 · 2016: 11 · 2015: 10 · 2014: 10 · 2013: 8 · 2012: 15
FWCI: 16.24
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords: nicotine, nicotine withdrawal, conditioned cues, rimonabant, endocannabinoid system, extinction resistance, conditioned reinforcement, nicotine self-administration, smoking cessation, nicotine dependence, relapse
MeSH terms: Rimonabant, Acoustic Stimulation, Animals, Cues, Dopamine, Environment, Extinction, Psychological, Light, Male, Motivation, Motor Activity, Synaptic Transmission, Nicotine, Piperidines, Pyrazoles, Self Administration, Substance Withdrawal Syndrome, Tobacco Use Disorder, Rats, Sprague-Dawley, Nicotinic Agonists, Receptor, Cannabinoid, CB1, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks